Form 4 for INO INOVIO PHARMACEUTICALS, INC.

Accepted 2022-03-09 00:00:00 ET · period of report 2022-03-08 · accession 0001055726-22-000014 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-03-09	2022-03-09	INO	Weiner David B.	Dir	S - Sale+OE	$3.33	-4,083	876.0K	-0.5%	-$13.6K
D	2022-03-09	2022-03-08	INO	Weiner David B.	Dir	M - OptEx	—	+11.7K	880.1K	+1%	—
D	2022-03-09	2022-03-08	INO	Weiner David B.	Dir	M - OptEx	$0.00	-11.7K	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-03-09	S	D	4,083	$3.33	876,041	D	—	—
2	Common	Common Stock	2022-03-08	M	A	11,666	—	880,124	D	—	—	(F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 8, 2020; 11,667 shares vested on March 8, 2021; 11,666 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
3	Derivative	Restricted Stock Unit	2022-03-08	M	D	11,666	$0.00	0	D	— · — to —	11,666 Common Stock	(F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 8, 2020; 11,667 shares vested on March 8, 2021; 11,666 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.